key: cord-0896653-unnnto6a
authors: Hai, Josephine; Shawa, Harrison; Kim-Lim, Penelope; Wang, Jenny Z.; Vy, Michelle; Fung, Maxwell A.; Sood, Apra; Tartar, Danielle M.
title: Systemic drug-related intertriginous and flexural exanthema (SDRIFE) induced by the Comirnaty Pfizer-BioNTech COVID-19 vaccine: A report of 2 cases
date: 2021-10-26
journal: JAAD Case Rep
DOI: 10.1016/j.jdcr.2021.10.016
sha: 30e2dd0d91ca4ab8b8c4a98232bbee7a025e23c0
doc_id: 896653
cord_uid: unnnto6a

nan

One month after rash onset, he presented to the emergency department due to uncontrolled pain 31 and itching of the rash. He had seen various other providers and had been prescribed topical 32 ketoconazole, triamcinolone, and oral terbinafine with no improvement. The patient was otherwise well with stable vitals. On exam, she had involvement of the neck, 

Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome

Symmetrical Drug-related Intertriginous and Flexural Exanthema Induced by Doxycycline

SDRIFE-like rash in COVID-19 patient: drug reaction or another cutaneous manifestation of SARS-CoV-2?

Systemic drug-related intertriginous and flexural exanthema like eruption after CoronaVac vaccine

Systemic contact dermatitis from thimerosal

Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine